This is similar to the data of Claus et al. [12] who found that 2.4% had pathogenic variants in BRCA2 and 0.8% in BRCA1 in a slightly older group of DCIS patients (mean age 53.8 years). This evidence concerns the gene BRCA2 and ductal breast carcinoma in situ.